Observational studies on the risk of cancer associated with tumor necrosis factor inhibitors in rheumatoid arthritis: A review of their methodologies and results
Authors:
Open Access
- 26 August 2011
- journal article
- review article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 64 (1) , 21-32
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Tumor necrosis factor α antagonist use and cancer in patients with rheumatoid arthritisArthritis & Rheumatism, 2006
- Anti-TNF Antibody Therapy in Rheumatoid Arthritis and the Risk of Serious Infections and MalignanciesJAMA, 2006
- Incidence of lymphoma in a large primary care derived cohort of cases of inflammatory polyarthritisAnnals of the Rheumatic Diseases, 2006
- Is there an association between anti-TNF monoclonal antibody therapy in rheumatoid arthritis and risk of malignancy and serious infection? Commentary on the meta-analysis by Bongartz et alArthritis Research & Therapy, 2006
- Skin cancer, rheumatoid arthritis, and tumor necrosis factor inhibitors.2005
- Risks of solid cancers in patients with rheumatoid arthritis and after treatment with tumour necrosis factor antagonistsAnnals of the Rheumatic Diseases, 2005
- Haematopoietic malignancies in rheumatoid arthritis: lymphoma risk and characteristics after exposure to tumour necrosis factor antagonistsAnnals of the Rheumatic Diseases, 2005
- EBV the prototypical human tumor virus—just how bad is it?Journal of Allergy and Clinical Immunology, 2005
- Analytic Strategies to Adjust Confounding using Exposure Propensity Scores and Disease Risk Scores: Nonsteroidal Antiinflammatory Drugs and Short-term Mortality in the ElderlyAmerican Journal of Epidemiology, 2005
- Tumor necrosis factor-? in the pathogenesis and treatment of cancerCurrent Opinion in Pharmacology, 2004